bims-sicedi Biomed News
on Sickle cell disease
Issue of 2026–03–08
three papers selected by
João Conrado Khouri dos Santos, Universidade de São Paulo



  1. Blood Adv. 2026 Mar 04. pii: bloodadvances.2025018716. [Epub ahead of print]
      Vaso-occlusion is a signature pathology of sickle cell disease (SCD). However, the lack of in vivo methods to observe individual blood cell dynamics in humans limits our understanding of occlusion formation mechanisms. We present a novel in vivo, non-invasive, label-free, and high-resolution imaging technique to study blood flow and sickled cell behavior in affected individuals. We used oblique back-illumination microscopy (OBM) to capture videos of 91.0 ± 42.3 sublingual capillaries in each of ten subjects with SCD before and after red cell transfusions and compared measurements to ten unaffected controls. With direct observation of blood cell activity, we identified microvascular occlusions initiated by red blood cells (RBCs) that adhered to the endothelium and caused mechanical vessel obstruction. Often, the RBCs were sickled. Then, in each observed vessel, we classified blood flow as fast, slow, or no flow, and counted adhered RBCs. Compared to controls, SCD subjects before transfusion had fewer fast-flowing vessels (48.7% vs. 77.7%, p=5.8x10-4), more no flow vessels (16.1% vs. 2.4%, p=0.0010), and more adhered RBCs (1.37 vs. 0.01 cells per vessel, p=0.0025). From before to after transfusion, SCD subjects' microvasculature had increased fast-flowing (48.7% vs. 65.8%, p=0.0098) and decreased no flow vessels (16.1% vs. 6.0%, p=0.0039); adhered RBCs decreased (1.37 vs. 0.71 cells per vessel, p=0.043). These hemorheological indices captured transfusion-induced changes to vascular dynamics and events leading to microvascular dysfunction and occlusion in SCD. Our findings demonstrate the potential of OBM to study vaso-occlusion pathobiology, accelerate therapeutic evaluation, and personalize treatment strategies in people with SCD.
    DOI:  https://doi.org/10.1182/bloodadvances.2025018716
  2. EJHaem. 2026 Apr;7(2): e70257
       Introduction: Sickle cell disease (SCD) is a hematologic disorder characterized by chronic hemolysis, vaso-occlusion, and end-organ dysfunction. Patients with SCD may experience acute episodes known as sickle cell crises, which are sudden, severe complications typically involving pain or organ-specific manifestations resulting from vaso-occlusion. Sickle cell hepatopathy includes acute and chronic liver complications, with cirrhosis contributing to inflammation and hepatic decompensation. The impact of cirrhosis on in-hospital outcomes remains unclear. This study examines the association between cirrhosis and in-hospital outcomes in adults hospitalized with Sickle cell disease using the 2021 National Inpatient Sample (NIS).
    Methodology: A retrospective cohort study using the 2021 NIS identified adults (≥ 18 years) hospitalized with sickle cell crises, stratified by cirrhosis status. Cirrhosis was identified through secondary diagnoses, and key variables included demographics, comorbidities, and hospital characteristics. Logistic regression models adjusted for confounders and for assessed outcomes. Survey weights ensured national representativeness (p < 0.05).
    Results: Hospitalized cirrhotic patients were older with more comorbidities. In-hospital mortality was higher in hospitalized cirrhotic patients (2.86% vs. 0.27%; adjusted OR 3.79, 95% CI 1.50-9.54; p = 0.005). Mechanical ventilation was more frequent (3.39% vs. 0.27%; adjusted OR 5.46, 95% CI 2.07-14.36; p = 0.001) and vasopressor use was higher but not statistically significant.
    Conclusion: Cirrhosis worsens in-hospital outcomes for patients hospitalized with SCC. Enhanced clinical monitoring and tailored management are important. Future studies should explore interventions to mitigate hepatic complications in SCC.
    Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
    Keywords:  hepatic dysfunction; in‐hospital mortality; liver cirrhosis; liver‐related morbidity; sickle cell anemia; vaso‐occlusion
    DOI:  https://doi.org/10.1002/jha2.70257
  3. J Community Genet. 2026 Mar 04. pii: 35. [Epub ahead of print]17(2):
      
    Keywords:  Disease management; Primary healthcare; Primary healthcare providers; Sickle cell disease
    DOI:  https://doi.org/10.1007/s12687-026-00867-x